CST3 and cancer: Lankisch et al.23 revealed that serum Cystatin C was an alternative to serum creatinine for monitoring kidney functions and GFR in pediatric cancer patients with solid tumors and hematological malignancies as it is less dependent on influential factors like weight, height, and muscle mass.